Product Information
IPRATROPIUM 0.03% SPRAY is a generic product labeled by NorthStar Rx LLC, priced at $0.3678 per ML under NDC 16714052601. Its NADAC has been published 221 times since Jul 13, 2022.
FDA first approved this application on Apr 18, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
21 ug/1
Manufacturer
NorthStar Rx LLCNDC
16714052601
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
IPRATROPIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076156FDA Approved
4/18/2003
TE Code
AB
On Market Since
2/22/2022
Pharmacological Classes
Price Statistics
The NADAC for IPRATROPIUM 0.03% SPRAY has been published 221 times since Jul 13, 2022, and over the history we have for it it has declined 55.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3678 per ML |
|---|---|
| All-time high | $0.9493 (Jul 12, 2023) |
| All-time low | $0.3488 (Jul 22, 2026) |
| 52-week high | $0.5706 |
| 52-week low | $0.3488 |
| Median price | $0.6145 |
| Average price | $0.6127 |
| Largest weekly change | +25.7% (Jun 21, 2023) |
| Weeks tracked | 221 |
| Tracking since | Jul 13, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ipratropium Bromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IPRATROPIUM 0.03% SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for IPRATROPIUM 0.03% SPRAY, manufactured by NorthStar Rx LLC, is $0.3678 per ML (NDC 16714052601), effective Sep 30, 2026.
How has the price of IPRATROPIUM 0.03% SPRAY changed over time?
Over the history we have for it, the NADAC for IPRATROPIUM 0.03% SPRAY has declined 55.8%. It has been tracked across 221 weekly CMS publications since Jul 13, 2022.
What are the highest and lowest recorded NADAC prices for IPRATROPIUM 0.03% SPRAY?
Since Jul 13, 2022, the NADAC for IPRATROPIUM 0.03% SPRAY has ranged from a low of $0.3488 (Jul 22, 2026) to a high of $0.9493 (Jul 12, 2023), with a median of $0.6145 per ML.
Are there cheaper alternatives to IPRATROPIUM 0.03% SPRAY?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IPRATROPIUM 0.03% SPRAY in a comparable dosage form, but none are currently priced below it.
Who manufactures IPRATROPIUM 0.03% SPRAY?
IPRATROPIUM 0.03% SPRAY (NDC 16714052601) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.